Start here if you're new
what it is
Air Products sells industrial gases like hydrogen, oxygen, and nitrogen that factories, chip plants, and refineries need every day.
how it gets paid
Last year Air Products made $12.0B in revenue. Hydrogen was the main engine at $3.6B, or 30% of sales.
why growth slowed
Revenue fell 0.5% last year. The 6% revenue growth matters most because full-year revenue had declined 0.5%.
what just happened
Latest quarter revenue hit $3.1B and EPS reached $3.04 as demand held up.
At a glance
A+ balance sheet — rock-solid finances — built to survive anything
100/100 earnings predictability — you can trust these numbers
22.2x trailing p/e — priced about right
2.7% dividend yield — cash in your pocket every quarter
10.0% return on capital — nothing to write home about
xvary composite: 68/100 — average
What they do
Air Products sells industrial gases like hydrogen, oxygen, and nitrogen that factories, chip plants, and refineries need every day.
If your refinery or chip plant needs hydrogen or nitrogen every day, you do not swap suppliers casually. Air Products has about 22,000 employees and gets 58% of sales from outside the U.S., which tells you this network is global, local, and hard to copy. Switching costs (changing a critical supplier) → operational hassle and plant risk → so customers usually stay put.
How they make money
$12.0B
annual revenue · their business grew -0.5% last year
Hydrogen
$3.6B
Atmospheric gases
$3.0B
Semiconductor materials
$1.8B
Natural gas liquefaction
$1.8B
Other process gases
$1.8B
The products that matter
core supply network
Industrial Gases
$12.0B revenue · 23.0% net margin
this is the whole business in one card. Revenue fell 0.5%, and the company still kept 23 cents of every dollar. That is why APD gets treated like infrastructure.
the cash engine
embedded customer model
On-site Contracts
100 / 100 predictability
the predictability score is the clue. Once pipes and supply systems are inside a customer facility, switching gets expensive and annoying. That makes revenue steadier than most industrial names.
switching hurts
future earnings project slate
Hydrogen Buildout
$15B+ spend · judged around 2027–2028
this is the strategic bet hanging over the stock. If these assets earn strong returns, today looks patient. If they do not, you funded a long construction cycle for mediocre payoff.
the valuation swing factor
Key numbers
$4.0B
2026 capex plan
That is about 31% of projected 2026 revenue, so you are funding a huge buildout before seeing the payoff.
22.2x
trailing p/e
You are paying a premium multiple for a business with projected sales growth of just 2.0%.
$16.4B
long-term debt
Debt equals 22% of capital, which is manageable, but it matters more when project spending is this heavy.
2.7%
dividend yield
You get paid to wait, but projected dividend growth slows to 1.5%, so income is not the main story.
Financial health
A+
strength
- balance sheet grade A+ — near the highest rating possible
- risk rank 2 — safer than 80% of stocks
- price stability 80 / 100
- long-term debt $16.4B (22% of capital)
- net profit margin 24.0% — keeps 24 cents of every dollar in revenue
- return on equity 18% — $0.18 profit for every $1 investors have put in
A+ with balance sheet grade and risk rank standing out. your money faces less risk here than at most public companies.
Total return vs. market
You invested $10,000 in APD 3 years ago → it's now worth $9,300.
The index would have given you $14,770.
source: institutional data · total return
What just happened
beat estimates
Latest quarter revenue hit $3.1B and EPS reached $3.04 as demand held up.
Revenue rose 6% vs. prior year and EPS rose 10% vs. prior year in the latest quarter. Consensus also showed a recent earnings result of $3.16 versus a $3.05 estimate, a 3.61% surprise.
$3.1B
revenue
$3.04
eps
6.0%
revenue growth
the number that mattered
The 6% revenue growth matters most because full-year revenue had declined 0.5%, so you need proof demand is turning back up.
-
air products should post solid fiscal 2026 first-quarter results (years begin october 1st).the global supplier of industrial gases continues to optimize its portfolio and spent all of fiscal 2025 cleaning up legacy items.
-
with that in mind, we look for the company to post adjusted earnings around $3.05 per share on revenues of $3.05 billion, reflecting increases of 7% and 4%, respectively, vs. prior year.
-
as air products executes against its fiveyear strategic roadmap, management is targeting further margin expansion and earnings growth moving forward.
-
management has signaled plans for nearly $4 billion in capital expenditures in fiscal 2026.this will be aimed at balancing investment in core industrial gas infrastructure while launching multiple projects focused on improving capacity and reaching new industrial markets.
-
against this backdrop, we expect fiscal 2026 adjusted earnings of $13.00 per share on revenues of $12.6 billion, which would mark increases of 8% and 5%, respectively.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
APD's risk stack is unusually clean: the core gas business looks steady, so most of the downside sits in the gap between billions spent today and returns promised later.
med
hydrogen buildout delays or weak returns
management is spending $15B+ on hydrogen and related projects that are meant to drive growth around 2027–2028. If those assets arrive late or earn less than planned, you sit through the spending without getting the earnings lift that justified it.
impact: ties up nearly $4B of 2026 capex before the payoff shows up
med
core growth stays too flat
annual revenue slipped 0.5% last year and full-year EPS was $12.03 versus $12.06 the year before. A stable business is useful. A stable business at 22.2x earnings needs something better than flat results to rerate higher.
impact: another year near $12–$13 EPS turns patience into the whole thesis
med
permitting and industrial approvals drag out the timeline
this is still a large-scale industrial infrastructure business. Projects do not need to fail to hurt you. Delays alone can push out returns and keep the stock in the waiting room longer than investors expected.
impact: slower approvals stretch the earnings timeline the market is already discounting
med
capex creeps above plan without clearer economics
nearly $4B of 2026 capex is already a large ask for a company that just posted flat annual EPS. If the spending bill rises again before investors get cleaner evidence on returns, the stock starts to look less defensive and more like a very polite capital sink.
impact: higher spend with the same $12–$13 earnings range would pressure valuation
$15B+ of project spending and nearly $4B of fiscal 2026 capex are being funded before the earnings fully arrive. If returns disappoint, the stock stops looking defensive and starts looking expensive.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
q1 fy2026 margin quality
watch the $3.05 eps and $3.05B revenue setup, but do not stop at the headline. Revenue can rise while the story stays stuck. Margin quality is the cleaner tell.
calendar
2026 capex pacing
management plans nearly $4B in capex for fiscal 2026. You want spend turning into visible milestones, not just a larger bill and another promise about 2027–2028.
risk
project returns, not just project completion
finished plants are nice. Earned returns are the point. Here's the thing: APD has told you a lot about spending, and less about project-level payoff. That gap is the risk.
trend
whether $13.00 eps starts looking conservative or fragile
the current frame is $13.00 per share on $12.6B revenue. If guidance firms up, the waiting period gets easier to tolerate. If it drifts lower, the stock will feel every quarter of delay.
Analyst rankings
short-term outlook
below average
momentum score 4 — analysts see weaker-than-average price performance over the next year. in human-speak, they think the business is steadier than the stock setup.
risk profile
below average risk
stability score 2 — safer than roughly 80% of stocks. This is a slow-moving industrial with an A+ balance sheet, not a balance-sheet accident waiting to happen.
chart momentum
bottom 5%
technical score 5 — the weakest rating on the scale. The chart has not been your friend, and institutions have not rushed in to argue.
earnings predictability
100 / 100
about as reliable as it gets. The irony is that predictable numbers do not guarantee exciting returns when capital spending is doing the drama.
source: institutional data
Institutional activity
institutions have been net selling for 3 consecutive quarters — 676 buyers vs. 798 sellers in 3q2025. total institutional holdings: 0.2B shares. net selling for 3 quarters.
source: institutional data
Price targets
3-5 year target range
$218
$401
$267
current price
$310
target midpoint · +16% from current · 3-5yr high: $485 (+80% · 18% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive